University of Tasmania
Browse

File(s) not publicly available

Metallothionein Treatment Attenuates Microglial Activation and Expression of Neurotoxic Quinolinic Acid Following Traumatic Brain Injury

journal contribution
posted on 2023-05-17, 01:07 authored by Chung, RS, Jacqueline LeungJacqueline Leung, Butler, CW, Chen, Y, Eaton, ED, Pankhurst, MW, Adrian WestAdrian West, Guillemin, GJ
The kynurenine pathway has been implicated as a major component of the neuroinflammatory response to brain injury and neurodegeneration. We found that the neurotoxic kynurenine pathway intermediate quinolinic acid (QUIN) is rapidly expressed, within 24 h, by reactive microglia following traumatic injury to the rodent neocortex. Furthermore, administration of the astrocytic protein metallothionein attenuated this neuroinflammatory response by reducing microglial activation (by approximately 30%) and QUIN expression. The suppressive effect of MT was confirmed upon cultured cortical microglia, with 1 lg/ml MT almost completely blocking interferon– gamma induced activation of microglia and QUIN expression. These results demonstrate the neuroimmunomodulatory properties of MT, which may have therapeutic applications for the treatment of traumatic brain injury.

History

Publication title

Neurotoxicity Research: An International Journal on Processes and Mechanisms in Neurodegeneration, Apoptosis, Neuroprotection and Regeneration

Volume

15

Issue

4

Pagination

381-389

ISSN

1029-8428

Department/School

Menzies Institute for Medical Research

Publisher

F P Graham Publishing Co

Place of publication

Po Box 370, Mountain Home, USA, Tn, 37684

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC